Select Publications
Conference Abstracts
2013, 'QTc PROLONGATION IN METHADONE AND BUPRENORPHINE MAINTAINED PATIENTS', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL, Vol. 32, pp. 47 - 47, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000326649400148&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2011, 'BUPRENORPHINE-NALOXONE VS WAIT LIST CONTROL RCT: HEALTH SERVICE UTILISATION AND HEALTH ECONOMIC OUTCOMES', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL, Vol. 30, pp. 39 - 40, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000297019700122&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2010, 'EFFECTIVENESS AND COST EFFECTIVENESS OF UNSUPERVISED BUPRENORPHINE-NALOXONE VERSUS WAIT LIST CONTROL RCT', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL, Vol. 29, pp. 23 - 23, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000284895600053&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2009, 'PRESCRIPTION DRUG MISUSE MODULE', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL PUBLISHING, INC, Vol. 28, pp. A27 - A28, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270916300086&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,